| Date | Event | Reminder | | No Upcoming Events |
|
| Date | Event | | 17-Nov-09 | Coverage initiated on Antares Pharma by Merriman | | 12-Nov-09 | ANTARES PHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits | | 9-Nov-09 | Antares Pharma, Inc. Earnings Call scheduled for 4:30 pm ET today | | 9-Nov-09 | ANTARES PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi | | 16-Oct-09 | Price hit new 52-week high ($1.31) | | 18-Sep-09 | ANTARES PHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibit | | 14-Aug-09 | ANTARES PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits | | 13-Aug-09 | ANTARES PHARMA, INC. Files SEC form 10-Q, Quarterly Report | | 13-Aug-09 | Antares Pharma, Inc. Earnings Call scheduled for 8:30 am ET today | | 24-Jul-09 | ANTARES PHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibit | | 29-Jun-09 | Price hit new 52-week high ($1.21) | | 5-Jun-09 | ANTARES PHARMA, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standa | | 5-Jun-09 | Price hit new 52-week high ($0.84) | | 13-May-09 | ANTARES PHARMA, INC. Files SEC form 10-Q, Quarterly Report | | 25-Mar-09 | ANTARES PHARMA, INC. Files SEC form 10-K, Annual Report |
|
| |
|
0.11% Nasdaq 
0.01%
Company Events
